Have a personal or library account? Click to login
Role of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib in the Management of Neuroblastoma Cover

Role of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib in the Management of Neuroblastoma

EABR. Experimental and Applied Biomedical Research
AHEAD OF PRINT
By: Yasemin Benderli Cihan  
Open Access
|Jan 2019

Authors

Yasemin Benderli Cihan

cihany@erciyes.edu.tr

Kayseri Education and Research Hospital, Department of Radiation Oncology,, Kayseri, Turkey
DOI: https://doi.org/10.2478/sjecr-2018-0066 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Journal RSS Feed
Language: English
Submitted on: Dec 4, 2018
|
Accepted on: Jul 27, 2018
|
Published on: Jan 10, 2019
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
neuroblastoma,
ALK inhibitors,
therapy,
children
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2019 Yasemin Benderli Cihan, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

AHEAD OF PRINT